These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 38275074)
1. A Review on the Development of Novel Heterocycles as α-Glucosidase Inhibitors for the Treatment of Type-2 Diabetes Mellitus. Patel P; Shah D; Bambharoliya T; Patel V; Patel M; Patel D; Bhavsar V; Padhiyar S; Patel B; Mahavar A; Patel R; Patel A Med Chem; 2024; 20(5):503-536. PubMed ID: 38275074 [TBL] [Abstract][Full Text] [Related]
2. Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview. Dhameja M; Gupta P Eur J Med Chem; 2019 Aug; 176():343-377. PubMed ID: 31112894 [TBL] [Abstract][Full Text] [Related]
3. An Updated Overview of Synthetic α-glucosidase Inhibitors: Chemistry and Bioactivities. Cai YS; Xie HX; Zhang JH; Li Y; Zhang J; Wang KM; Jiang CS Curr Top Med Chem; 2023; 23(26):2488-2526. PubMed ID: 37818579 [TBL] [Abstract][Full Text] [Related]
4. Tyramine Derivatives as Potent Therapeutics for Type 2 Diabetes: Synthesis and Bashir MA; Javaid K; Shaikh M; Choudhary MI; Siddiqui H Med Chem; 2020; 16(8):1124-1135. PubMed ID: 32003674 [TBL] [Abstract][Full Text] [Related]
5. Synthetic α-glucosidase inhibitors as promising anti-diabetic agents: Recent developments and future challenges. Mushtaq A; Azam U; Mehreen S; Naseer MM Eur J Med Chem; 2023 Mar; 249():115119. PubMed ID: 36680985 [TBL] [Abstract][Full Text] [Related]
6. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase. Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651 [TBL] [Abstract][Full Text] [Related]
7. Towards multi-target antidiabetic agents: In vitro and in vivo evaluation of 3,5-disubstituted indolin-2-one derivatives as novel α-glucosidase inhibitors. Klochkov VG; Bezsonova EN; Dubar M; Melekhina DD; Temnov VV; Zaryanova EV; Lozinskaya NA; Babkov DA; Spasov AA Bioorg Med Chem Lett; 2022 Jan; 55():128449. PubMed ID: 34780899 [TBL] [Abstract][Full Text] [Related]
8. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation. Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes. Alasmary FAS; Abdullah DA; Masand VH; Ben Bacha A; Omar Ebeid AM; El-Araby ME; Alafeefy AM J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2395985. PubMed ID: 39311475 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose. Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132 [TBL] [Abstract][Full Text] [Related]
11. Structure-Activity Relationships of Natural and Synthetic Indole-Derived Scaffolds as α-Glucosidase Inhibitors: A Mini-Review. Wang J; Lu S; Sheng R; Fan J; Wu W; Guo R Mini Rev Med Chem; 2020; 20(17):1791-1818. PubMed ID: 32560604 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, α-glucosidase inhibitory activity and in silico study of tris-indole hybrid scaffold with oxadiazole ring: As potential leads for the management of type-II diabetes mellitus. Taha M; Rahim F; Imran S; Ismail NH; Ullah H; Selvaraj M; Javid MT; Salar U; Ali M; Khan KM Bioorg Chem; 2017 Oct; 74():30-40. PubMed ID: 28750203 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes. Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114 [TBL] [Abstract][Full Text] [Related]
14. New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study. Adib M; Peytam F; Rahmanian-Jazi M; Mahernia S; Bijanzadeh HR; Jahani M; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Mahdavi M; Larijani B Eur J Med Chem; 2018 Jul; 155():353-363. PubMed ID: 29902721 [TBL] [Abstract][Full Text] [Related]
15. Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II. Gamal MA; Fahim SH; Giovannuzzi S; Fouad MA; Bonardi A; Gratteri P; Supuran CT; Hassan GS Eur J Med Chem; 2024 May; 271():116434. PubMed ID: 38653067 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and In Silico Analysis of New Polyheterocyclic Molecules Derived from [1,4]-Benzoxazin-3-one and Their Inhibitory Effect against Pancreatic α-Amylase and Intestinal α-Glucosidase. Ellouz M; Ihammi A; Baraich A; Farihi A; Addichi D; Loughmari S; Sebbar NK; Bouhrim M; A Mothana R; M Noman O; Eto B; Chigr F; Chigr M Molecules; 2024 Jun; 29(13):. PubMed ID: 38999038 [TBL] [Abstract][Full Text] [Related]
17. Exploration of aroyl/heteroaroyl iminothiazolines featuring 2,4,5-trichlorophenyl moiety as a new class of potent, selective, and in vitro efficacious glucosidase inhibitors. Kazmi M; Zaib S; Amjad ST; Khan I; Ibrar A; Saeed A; Iqbal J Bioorg Chem; 2017 Oct; 74():134-144. PubMed ID: 28780150 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies. Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920 [TBL] [Abstract][Full Text] [Related]
19. Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents. Tafesse TB; Bule MH; Khoobi M; Faramarzi MA; Abdollahi M; Amini M Mini Rev Med Chem; 2020; 20(2):134-151. PubMed ID: 31553294 [TBL] [Abstract][Full Text] [Related]
20. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation. Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]